Farallon Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Farallon Capital Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$10.5M	Buy
2023 Q3	–	Sell
2023 Q2	$4.73M	Buy
2021 Q1	–	Sell
2020 Q4	$12.2M	Buy
2018 Q4	–	Sell
2018 Q3	$15.7M	Sell
2018 Q2	$23M	Buy
2018 Q1	$13.7M	Sell
2017 Q4	$21.9M	Buy